Profile data is unavailable for this security.
About the company
ExpreS2ion Biotech Holding AB is a Sweden-based biopharmaceutical company. The Company specializes in developing cell lines and processes based on a non-viral Drosophila S2 cells expression system. The Company's ExpreS2 recombinant protein expression platform supports all phases of drug discovery, research and development and manufacturing. ExpreS2 is a non-viral insect cell expression system that establishes stable polyclonal pools that provide high-protein expression levels without selection pressure. The system is designed for transient or stable transfections using vector deoxyribonucleic acid containing a hybrid promoter. It also ensures high cell density without aggregation or toxic metabolite build-up issues. Through the joint venture AdaptVac ApS, the Company applies a Plug-and-Play Virus Like Particle technology for development of therapeutic and prophylactic vaccines within oncology, infectious diseases and immunological disorders.
- Revenue in SEK (TTM)8.80m
- Net income in SEK-95.99m
- Incorporated2015
- Employees28.00
- LocationExpreS2ion Biotech Holding ABRonnowsgatan 8 CHELSINGBORG 25225SwedenSWE
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| PCI Biotech Holding ASA | 2.97m | -20.20m | 59.32m | 7.00 | -- | 1.53 | -- | 19.95 | -0.5443 | -0.5443 | 0.0801 | 1.05 | 0.0556 | -- | 0.6848 | 427,142.80 | -37.78 | -36.44 | -41.97 | -40.14 | -- | -- | -679.43 | -1,055.43 | -- | -- | 0.0081 | -- | -37.05 | -20.78 | 63.13 | -- | -- | -- |
| Orphazyme A/S | 0.00 | -40.68m | 60.50m | 1.00 | -- | 2.72 | -- | -- | -737.75 | -737.75 | 0.00 | 403.34 | 0.00 | -- | -- | 0.00 | -68.42 | -76.08 | -94.18 | -105.34 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | 32.00 | -- | -- | -- |
| Coegin Pharma AB | 0.00 | -27.98m | 61.23m | -- | -- | 4.70 | -- | -- | -2.67 | -2.67 | 0.00 | 0.6404 | 0.00 | -- | -- | -- | -125.24 | -122.02 | -201.53 | -154.70 | -- | -- | -- | -- | -- | -170.65 | -- | -- | -- | -- | 20.60 | -- | -- | -- |
| Double Bond Phrmcutcl Intrntnl AB (publ) | 1.37m | -17.34m | 63.85m | 10.00 | -- | 11.37 | -- | 46.59 | -0.1837 | -0.1837 | 0.0136 | 0.0556 | 0.1016 | -- | 18.59 | 137,033.00 | -128.49 | -80.90 | -198.98 | -106.45 | -241.22 | -686.41 | -1,265.24 | -1,360.03 | -- | -217.55 | 0.00 | -- | 10.25 | 135.07 | -14.36 | -- | -- | -- |
| Chosa Oncology AB | 73.00k | -23.94m | 64.74m | -- | -- | 3.72 | -- | 886.91 | -0.3524 | -0.3524 | 0.0013 | 0.2684 | 0.003 | -- | 0.013 | -- | -96.68 | -51.96 | -178.66 | -61.92 | -- | -- | -32,798.63 | -708.47 | -- | -97.97 | -- | -- | -98.21 | -- | 28.33 | -- | -- | -- |
| Abera Bioscience AB | 0.00 | -16.72m | 69.09m | -- | -- | 11.51 | -- | -- | -1.24 | -1.24 | 0.00 | 0.391 | 0.00 | -- | -- | -- | -115.63 | -79.43 | -149.06 | -96.11 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 13.73 | -- | -- | -- |
| SoftOx Solutions AS | 6.94m | -41.85m | 70.31m | -- | -- | -- | -- | 10.13 | -1.98 | -1.98 | 0.3286 | -0.0127 | 0.081 | -- | 1.60 | -- | -48.81 | -50.83 | -82.20 | -64.58 | -- | -- | -602.91 | -646.67 | 0.1745 | -3.45 | -- | -- | -1.88 | 10.06 | 40.85 | -- | 39.43 | -- |
| Combigene AB | 5.54m | -35.67m | 73.86m | 8.00 | -- | 0.6342 | -- | 13.32 | -1.80 | -1.80 | 0.28 | 5.88 | 0.0398 | -- | 2.63 | 693,015.00 | -25.58 | -13.00 | -26.56 | -14.58 | -- | -- | -643.32 | -58.77 | -- | -- | 0.00 | -- | -79.23 | 268.58 | -479.27 | -- | -24.02 | -- |
| ViroGates A/S | 8.72m | -18.89m | 74.31m | 10.00 | -- | 2.80 | -- | 8.52 | -6.12 | -6.12 | 1.61 | 2.64 | 0.2653 | 0.2654 | 3.15 | 558,300.00 | -57.47 | -46.58 | -63.01 | -52.09 | 78.83 | 77.91 | -216.66 | -238.01 | 8.56 | -23.89 | 0.2376 | -- | -45.01 | 10.98 | -25.40 | -- | -- | -- |
| ExpreS2ion Biotech Holding AB | 8.80m | -95.99m | 74.74m | 28.00 | -- | 1.23 | -- | 8.49 | -2.12 | -2.12 | 0.1895 | 1.19 | 0.0832 | -- | 9.91 | -- | -90.72 | -64.80 | -113.72 | -77.46 | -109.74 | -1.94 | -1,090.91 | -532.25 | -- | -- | 0.0045 | -- | 43.07 | -0.1561 | 19.07 | -- | 19.90 | -- |
| Spago Nanomedical AB (publ) | 1.20m | -42.22m | 76.63m | 13.00 | -- | 1.81 | -- | 63.70 | -0.3818 | -0.3818 | 0.0115 | 0.1882 | 0.0093 | -- | 5.74 | 92,538.46 | -32.61 | -20.19 | -35.38 | -20.97 | 247.55 | -- | -3,509.81 | -4,853.45 | -- | -- | -- | -- | 14.14 | -- | -7.72 | -- | -- | -- |
| Prolight Diagnostics AB (publ) | 0.00 | -27.75m | 77.97m | -- | -- | 0.2246 | -- | -- | -0.0984 | -0.0984 | 0.00 | 0.6946 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -13.84 | -- |
| Immunovia AB (publ) | 1.21m | -260.73m | 84.33m | 11.00 | -- | 1.93 | -- | 69.58 | -6.06 | -6.06 | 0.0276 | 0.9648 | 0.0075 | 58.23 | 14.96 | 110,181.80 | -160.93 | -41.33 | -194.89 | -44.24 | -5,523.76 | -7,553.76 | -21,512.13 | -20,879.29 | 2.03 | -- | 0.1675 | -- | 37.55 | 36.48 | -84.09 | -- | -50.93 | -- |
| Bioextrax AB publ | 2.06m | -21.51m | 86.31m | -- | -- | 3.60 | -- | 41.96 | -0.8026 | -0.8026 | 0.0769 | 0.6968 | 0.0681 | -- | 124.67 | -- | -71.18 | -86.39 | -82.24 | -110.84 | 34.95 | -- | -1,045.55 | -2,119.90 | -- | -- | -- | -- | 420.51 | 24.40 | -15.21 | -- | 56.86 | -- |
| Dextech Medical AB | 0.00 | -4.57m | 92.06m | 1.00 | -- | 2.85 | -- | -- | -0.2473 | -0.2473 | 0.00 | 1.75 | 0.00 | -- | -- | -- | -13.04 | -28.96 | -13.21 | -29.94 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | 12.89 | -- | 0.412 | -- |
| Ziccum AB | 3.75m | -21.41m | 92.23m | 8.00 | -- | 9.69 | -- | 24.62 | -1.54 | -1.54 | 0.2701 | 0.6191 | 0.1553 | -- | 2.01 | 468,375.00 | -88.74 | -68.51 | -109.73 | -76.47 | -- | -- | -571.44 | -2,598.03 | -- | -- | 0.0908 | -- | -- | 75.20 | 25.62 | -- | -13.45 | -- |
